Erytech Pharma S.A. buy tbackenh
Start price
31.03.17
/
50%
€28.20
Target price
02.10.17
€32.00
Performance (%)
-17.59%
End price
02.10.17
€23.24
Summary
This prediction ended on 02.10.17 with a price of €23.24. The prediction for Erytech Pharma S.A. disappointed with a performance of -17.59%. tbackenh has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Erytech Pharma S.A. | - | - | - | - |
iShares Core DAX® | -1.816% | -2.419% | 12.070% | 14.356% |
iShares Nasdaq 100 | 4.333% | 8.073% | 32.493% | 59.393% |
iShares Nikkei 225® | 0.657% | 1.234% | 2.682% | 5.342% |
iShares S&P 500 | 2.968% | 4.613% | 26.496% | 49.719% |
Comments by tbackenh for this prediction
In the thread Erytech Pharma S.A. diskutieren
Erytech Pharma S.A.
Phase 2 eines Bauchspeicheldrüsenkrebsmedikamentes erfolgreich abgeschlossen, könnte 2017 richtig abgehen.
(Laufzeit überschritten)
Stopped prediction by tbackenh for Erytech Pharma S.A.
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€19.25
26.09.16
26.09.16
€22.00
27.03.17
27.03.17
-25.71%
27.03.17
27.03.17